Searched for
SUNIL VARMA
No parties. No drama. Ajith Kumar's reaction to Good Bad Ugly’s box-office success will stun youAjith Kumar's film, Good Bad Ugly, is a box office success. Director Adhik Ravichandran shares Ajith's grounded perspective on fame. Ajith ...- PNB scam: Gitanjali Group's ex-staffer appears in court, gets interim bail; CBI seeks his custodyA special anti-money laundering court in India granted interim bail to Sunil Varma, a former top executive of Gitanjali Group, accused of t...
- PNB scam: Court suspends non-bailable warrant against top executive of Gitanjali GroupA special anti-money laundering court suspended the non-bailable warrant against Sunil Varma, former Gitanjali Group executive linked to th...
- Reduce Dr. Lal Pathlabs, target price Rs 1875: Yes SecuritiesReduce Dr. Lal Pathlabs at a price target of Rs 1875.
- Buy Dr. Lal Pathlabs, target price Rs 2620: JM FinancialDr. Lal Pathlabs, incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 15012.92 Crore) operating in Hospitals & A...
- Buy Dr. Lal Pathlabs, target price Rs 2820: BNP Paribas SecuritiesPromoters held 55.05 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.37 per cent, DIIs 6.27 per cent.
- Buy Dr. Lal Pathlabs, target Rs 1,249: Dharmesh ShahBuy Dr. Lal Pathlabs Ltd. at a price target of Rs 1249.0 and a stoploss at Rs 1136 from entry point.
- Buy Dr Lal Pathlabs, target Rs 1,235: Dharmesh ShahBuy Dr. Lal Pathlabs Ltd. at a price target of Rs 1235.0 and a stoploss at Rs 1148 from entry point.
- Buy Dr. Lal Pathlabs, target Rs 900: Edelweiss Financial ServicesBuy Dr. Lal Pathlabs at a price target of Rs 900. Time period given by analyst is a year when Dr. Lal Pathlabs price can reach defined targ...
- Gitanjali Gems Q2 net plunges 75 pc to Rs 37.82 croreThe company had clocked a net profit of Rs 151.65 crore for the same quarter last year.
Load More
